Roger Dansey

Last updated on 2016-08-03T22:10+0300.

About this image

sign

Quotes... Extracted quotes from

Roger Dansey said : “At this year’s ASH meeting, ADCETRIS will be featured in 18 data presentations, including five-year analyses from the ECHELON-1 and ECHELON-2 phase 3 frontline trials,” External link

4-traders Thursday, November 5, 2020 4:32:00 PM EAT

Roger Dansey said : "This is the first trial to report objective responses in patients with advanced urothelial cancer who had previously received immunotherapy but were ineligible for cisplatin in this setting due to inadequate kidney function or other conditions," External link

news-yahoo Monday, October 12, 2020 2:33:00 PM EAT

Roger Dansey said : "This is the first trial to report objective responses in patients with advanced urothelial cancer who had previously received immunotherapy but were ineligible for cisplatin in this setting due to inadequate kidney function or other conditions," External link

prnewswire Monday, October 12, 2020 2:09:00 PM EAT

Roger Dansey said : “Tisotumab vedotin has demonstrated meaningful clinical activity in patients with recurrent and/or metastatic cervical cancer for whom there is a high unmet need for new therapies,” External link

4-traders Monday, September 21, 2020 6:08:00 PM EAT

Roger Dansey said : "These survival results from the confirmatory trial for PADCEV are welcome news for patients whose cancer has progressed after platinum-based chemotherapy and immunotherapy," External link

news-yahoo Friday, September 18, 2020 2:47:00 PM EAT

Roger Dansey said : "These survival results from the confirmatory trial for PADCEV are welcome news for patients whose cancer has progressed after platinum-based chemotherapy and immunotherapy," External link

prnewswire Friday, September 18, 2020 2:45:00 PM EAT

Roger Dansey said : “These survival results from the confirmatory trial for PADCEV are welcome news for patients whose cancer has progressed after platinum-based chemotherapy and immunotherapy,” External link

4-traders Friday, September 18, 2020 2:02:00 PM EAT

Roger Dansey said : “At the ESMO Virtual Congress, we will be sharing important updates from our broad oncology portfolio of both marketed and investigational therapies, including an oral presentation of full data from the phase 2 trial evaluating tisotumab vedotin in recurrent or metastatic cervical cancer,” External link

4-traders Thursday, August 27, 2020 3:20:00 PM EAT

Roger Dansey said : “Available therapies upon progression after first line chemotherapy in recurrent or metastatic cervical cancer are limited, and there is a significant unmet need for new treatment options,” External link

4-traders Tuesday, June 30, 2020 12:01:00 AM EAT

Roger Dansey said : “This is an important step in our investigation of PADCEV in combination with pembrolizumab as a first-line therapy for patients with advanced urothelial cancer who are unable to receive cisplatin-based chemotherapy,” External link

businesswire Thursday, February 20, 2020 7:39:00 AM EAT

Roger Dansey said : "These updated data are encouraging and provide support for the recently initiated phase 3 trial EV-302 that includes an arm evaluating PADCEV in this platinum-free combination in the first-line setting," External link

news-yahoo Tuesday, February 11, 2020 1:22:00 AM EAT

Roger Dansey said : "These updated data are encouraging and provide support for the recently initiated phase 3 trial EV-302 that includes an arm evaluating PADCEV in this platinum-free combination in the first-line setting," External link

prnewswire Tuesday, February 11, 2020 1:05:00 AM EAT

Roger Dansey said : "PADCEV is the first antibody-drug conjugate approved for patients facing this aggressive disease, and it is the culmination of years of innovative work on this technology," External link

prnewswire Thursday, December 19, 2019 6:11:00 AM EAT

Roger Dansey said : "PADCEV is the first antibody-drug conjugate approved for patients facing this aggressive disease, and it is the culmination of years of innovative work on this technology," External link

news-yahoo Thursday, December 19, 2019 5:18:00 AM EAT

Roger Dansey disse : "Durante décadas, o padrão de atendimento para o tratamento do linfoma de Hodgkin na linha de frente foi a quimioterapia combinada, chamada de ABVD. Infelizmente, cerca de 30% dos pacientes com linfoma de Hodgkin em estágio avançado não respondem ou apresentam recidiva após o tratamento com esta terapia" External link

noticias-terra-br Wednesday, December 11, 2019 4:06:00 AM EAT

Roger Dansey disse : "Durante décadas, o padrão de atendimento para o tratamento do linfoma de Hodgkin na linha de frente foi a quimioterapia combinada, chamada de ABVD. Infelizmente, cerca de 30% dos pacientes com linfoma de Hodgkin em estágio avançado não respondem ou apresentam recidiva após o tratamento com esta terapia" External link

em Wednesday, December 11, 2019 3:36:00 AM EAT

Roger Dansey said : "For decades, the standard of care for the treatment of frontline Hodgkin lymphoma has been combination chemotherapy, called ABVD. Unfortunately, approximately 30 percent of patients with advanced stage Hodgkin lymphoma do not respond or relapse following treatment with this therapy," External link

afp-en Monday, December 9, 2019 6:00:00 PM EAT

Roger Dansey said : “We continue to evaluate ADCETRIS in combination with novel therapies, such as checkpoint inhibitors, with the goal of identifying new options for CD30-expressing lymphomas where there is high unmet need,” External link

4-traders Saturday, December 7, 2019 10:59:00 PM EAT

Roger Dansey said : “We look forward to initiating a randomized phase 3 trial in patients with previously untreated locally advanced or metastatic urothelial cancer,” External link

4-traders Monday, December 2, 2019 4:39:00 PM EAT

Roger Dansey said : "Collaborating with BeiGene on this product candidate has the potential to accelerate its availability both globally and in several key geographic regions, notably China where there is an unmet medical need for anti-cancer therapies," External link

4-traders Wednesday, November 6, 2019 2:05:00 AM EAT

Roger Dansey said : "There is an unmet clinical need for new treatments for patients with HER2-positive metastatic colorectal cancer," External link

finanznachrichten-en Sunday, September 29, 2019 5:45:00 PM EAT

Roger Dansey said : “There is an unmet clinical need for new treatments for patients with HER2-positive metastatic colorectal cancer,” External link

4-traders Sunday, September 29, 2019 5:17:00 PM EAT

Roger Dansey said : "These data are encouraging and support further exploration of a potential platinum-free combination of pembrolizumab and the investigational agent enfortumab vedotin," External link

finanznachrichten-en Saturday, September 28, 2019 11:41:00 AM EAT

Roger Dansey said : “These data are encouraging and support further exploration of a potential platinum-free combination of pembrolizumab and the investigational agent enfortumab vedotin,” External link

4-traders Saturday, September 28, 2019 10:04:00 AM EAT

Roger Dansey said : “We look forward to the presentation featuring antibody-drug conjugate enfortumab vedotin in combination with the immune therapy pembrolizumab in patients with previously untreated advanced urothelial cancer,” External link

4-traders Tuesday, September 17, 2019 3:17:00 PM EAT

Roger Dansey said : “Despite recent approvals of multiple checkpoint inhibitors for previously treated locally advanced or metastatic urothelial cancer, there remains a high unmet need for effective treatments upon progression after initial chemotherapy and immunotherapy,” External link

4-traders Thursday, March 28, 2019 10:28:00 AM EAT

Roger Dansey disse : "Esta é a sexta indicação aprovada pela FDA para o ADCETRIS em tumores malignos linfoides e a segunda como um tratamento de primeira linha em combinação com quimioterapia" External link

em Friday, December 7, 2018 11:55:00 AM EAT

Roger Dansey disse : "Esta é a sexta indicação aprovada pela FDA para o ADCETRIS em tumores malignos linfoides e a segunda como um tratamento de primeira linha em combinação com quimioterapia" External link

noticias-terra-br Friday, December 7, 2018 11:49:00 AM EAT

Roger Dansey sagte : "Dies ist die sechste von der FDA zugelassene Indikation für ADCETRIS bei lymphatischen Malignomen und die zweite als Erstbehandlung in Kombination mit Chemotherapie" External link

finanznachrichten-en Thursday, December 6, 2018 10:38:00 AM EAT

Roger Dansey said : "This initial evaluation of the combination of Keytruda and Halaven is encouraging and represents an important part of our multi-pronged effort to bring forward new potential approaches for patients with this type of cancer," External link

rttnews Monday, December 12, 2016 4:19:00 PM EAT

Roger Dansey said : "Little progress has been made in metastatic triple-negative breast cancer, which is an aggressive and difficult-to-treat cancer. This initial evaluation of the combination of KEYTRUDA and HALAVEN is encouraging and represents an important part of our multi-pronged effort to bring forward new potential approaches for patients with this type of cancer," External link

prnewswire Monday, December 12, 2016 3:31:00 PM EAT

Roger Dansey told : “Immunotherapy is certainly the future when it comes to treating cancer… The problem with any treatment that is not immune based is that cancer cells can find a way to circumvent whatever the treatment is,” External link

jordantimes Sunday, October 16, 2016 3:43:00 AM EAT

Roger Dansey said : "Now, with longer follow-up, we continue to show clinically meaningful outcomes with KEYTRUDA as monotherapy in these ipilimumab-refractory patients," External link

finanznachrichten-en Saturday, October 8, 2016 5:19:00 PM EAT

Roger Dansey said : “Now, with longer follow-up, we continue to show clinically meaningful outcomes with KEYTRUDA as monotherapy in these ipilimumab-refractory patients,” External link

marketwatch Saturday, October 8, 2016 4:13:00 PM EAT

Roger Dansey said : “Now, with longer follow-up, we continue to show clinically meaningful outcomes with KEYTRUDA as monotherapy in these ipilimumab-refractory patients,” External link

4-traders Saturday, October 8, 2016 4:11:00 PM EAT

Roger Dansey said : “We have a growing body of evidence of KEYTRUDA’s activity in a range of cancers and treatment settings including the first-line treatment of patients with advanced urothelial cancer who will not tolerate cisplatin-based therapy,” External link

marketwatch Saturday, October 8, 2016 9:26:00 AM EAT



Key Titles and Phrases Count Lang Last Seen
vice president100.00%EN12/12/201612/12/2016
Names Lang Count
Roger DanseyEN90.00%
Roger DanseyIT10.00%


 
Show/hide duplicate news articles.
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Saturday, November 28, 2020

5:18:00 AM EAT

Languages Collapse menu...Expand menu...

Select your languages

af
am
ar
de
en
es
fr
ha
pt
rw
sw
all
Show additional languagesHide additional languages

Interface:

Legend Collapse menu...Expand menu...


Quotes... Explore Relations


EMM Visual Explorer


AfricaBrief

Roger Dansey

Last updated on 2016-08-03T22:10+0300.

About this image

sign

Quotes... Extracted quotes from

Roger Dansey said : “At this year’s ASH meeting, ADCETRIS will be featured in 18 data presentations, including five-year analyses from the ECHELON-1 and ECHELON-2 phase 3 frontline trials,” External link

4-traders Thursday, November 5, 2020 4:32:00 PM EAT

Roger Dansey said : "This is the first trial to report objective responses in patients with advanced urothelial cancer who had previously received immunotherapy but were ineligible for cisplatin in this setting due to inadequate kidney function or other conditions," External link

news-yahoo Monday, October 12, 2020 2:33:00 PM EAT

Roger Dansey said : "This is the first trial to report objective responses in patients with advanced urothelial cancer who had previously received immunotherapy but were ineligible for cisplatin in this setting due to inadequate kidney function or other conditions," External link

prnewswire Monday, October 12, 2020 2:09:00 PM EAT

Roger Dansey said : “Tisotumab vedotin has demonstrated meaningful clinical activity in patients with recurrent and/or metastatic cervical cancer for whom there is a high unmet need for new therapies,” External link

4-traders Monday, September 21, 2020 6:08:00 PM EAT

Roger Dansey said : "These survival results from the confirmatory trial for PADCEV are welcome news for patients whose cancer has progressed after platinum-based chemotherapy and immunotherapy," External link

news-yahoo Friday, September 18, 2020 2:47:00 PM EAT

Roger Dansey said : "These survival results from the confirmatory trial for PADCEV are welcome news for patients whose cancer has progressed after platinum-based chemotherapy and immunotherapy," External link

prnewswire Friday, September 18, 2020 2:45:00 PM EAT

Roger Dansey said : “These survival results from the confirmatory trial for PADCEV are welcome news for patients whose cancer has progressed after platinum-based chemotherapy and immunotherapy,” External link

4-traders Friday, September 18, 2020 2:02:00 PM EAT

Roger Dansey said : “At the ESMO Virtual Congress, we will be sharing important updates from our broad oncology portfolio of both marketed and investigational therapies, including an oral presentation of full data from the phase 2 trial evaluating tisotumab vedotin in recurrent or metastatic cervical cancer,” External link

4-traders Thursday, August 27, 2020 3:20:00 PM EAT

Roger Dansey said : “Available therapies upon progression after first line chemotherapy in recurrent or metastatic cervical cancer are limited, and there is a significant unmet need for new treatment options,” External link

4-traders Tuesday, June 30, 2020 12:01:00 AM EAT

Roger Dansey said : “This is an important step in our investigation of PADCEV in combination with pembrolizumab as a first-line therapy for patients with advanced urothelial cancer who are unable to receive cisplatin-based chemotherapy,” External link

businesswire Thursday, February 20, 2020 7:39:00 AM EAT

Roger Dansey said : "These updated data are encouraging and provide support for the recently initiated phase 3 trial EV-302 that includes an arm evaluating PADCEV in this platinum-free combination in the first-line setting," External link

news-yahoo Tuesday, February 11, 2020 1:22:00 AM EAT

Roger Dansey said : "These updated data are encouraging and provide support for the recently initiated phase 3 trial EV-302 that includes an arm evaluating PADCEV in this platinum-free combination in the first-line setting," External link

prnewswire Tuesday, February 11, 2020 1:05:00 AM EAT

Roger Dansey said : "PADCEV is the first antibody-drug conjugate approved for patients facing this aggressive disease, and it is the culmination of years of innovative work on this technology," External link

prnewswire Thursday, December 19, 2019 6:11:00 AM EAT

Roger Dansey said : "PADCEV is the first antibody-drug conjugate approved for patients facing this aggressive disease, and it is the culmination of years of innovative work on this technology," External link

news-yahoo Thursday, December 19, 2019 5:18:00 AM EAT

Roger Dansey disse : "Durante décadas, o padrão de atendimento para o tratamento do linfoma de Hodgkin na linha de frente foi a quimioterapia combinada, chamada de ABVD. Infelizmente, cerca de 30% dos pacientes com linfoma de Hodgkin em estágio avançado não respondem ou apresentam recidiva após o tratamento com esta terapia" External link

noticias-terra-br Wednesday, December 11, 2019 4:06:00 AM EAT

Roger Dansey disse : "Durante décadas, o padrão de atendimento para o tratamento do linfoma de Hodgkin na linha de frente foi a quimioterapia combinada, chamada de ABVD. Infelizmente, cerca de 30% dos pacientes com linfoma de Hodgkin em estágio avançado não respondem ou apresentam recidiva após o tratamento com esta terapia" External link

em Wednesday, December 11, 2019 3:36:00 AM EAT

Roger Dansey said : "For decades, the standard of care for the treatment of frontline Hodgkin lymphoma has been combination chemotherapy, called ABVD. Unfortunately, approximately 30 percent of patients with advanced stage Hodgkin lymphoma do not respond or relapse following treatment with this therapy," External link

afp-en Monday, December 9, 2019 6:00:00 PM EAT

Roger Dansey said : “We continue to evaluate ADCETRIS in combination with novel therapies, such as checkpoint inhibitors, with the goal of identifying new options for CD30-expressing lymphomas where there is high unmet need,” External link

4-traders Saturday, December 7, 2019 10:59:00 PM EAT

Roger Dansey said : “We look forward to initiating a randomized phase 3 trial in patients with previously untreated locally advanced or metastatic urothelial cancer,” External link

4-traders Monday, December 2, 2019 4:39:00 PM EAT

Roger Dansey said : "Collaborating with BeiGene on this product candidate has the potential to accelerate its availability both globally and in several key geographic regions, notably China where there is an unmet medical need for anti-cancer therapies," External link

4-traders Wednesday, November 6, 2019 2:05:00 AM EAT

Roger Dansey said : "There is an unmet clinical need for new treatments for patients with HER2-positive metastatic colorectal cancer," External link

finanznachrichten-en Sunday, September 29, 2019 5:45:00 PM EAT

Roger Dansey said : “There is an unmet clinical need for new treatments for patients with HER2-positive metastatic colorectal cancer,” External link

4-traders Sunday, September 29, 2019 5:17:00 PM EAT

Roger Dansey said : "These data are encouraging and support further exploration of a potential platinum-free combination of pembrolizumab and the investigational agent enfortumab vedotin," External link

finanznachrichten-en Saturday, September 28, 2019 11:41:00 AM EAT

Roger Dansey said : “These data are encouraging and support further exploration of a potential platinum-free combination of pembrolizumab and the investigational agent enfortumab vedotin,” External link

4-traders Saturday, September 28, 2019 10:04:00 AM EAT

Roger Dansey said : “We look forward to the presentation featuring antibody-drug conjugate enfortumab vedotin in combination with the immune therapy pembrolizumab in patients with previously untreated advanced urothelial cancer,” External link

4-traders Tuesday, September 17, 2019 3:17:00 PM EAT

Roger Dansey said : “Despite recent approvals of multiple checkpoint inhibitors for previously treated locally advanced or metastatic urothelial cancer, there remains a high unmet need for effective treatments upon progression after initial chemotherapy and immunotherapy,” External link

4-traders Thursday, March 28, 2019 10:28:00 AM EAT

Roger Dansey disse : "Esta é a sexta indicação aprovada pela FDA para o ADCETRIS em tumores malignos linfoides e a segunda como um tratamento de primeira linha em combinação com quimioterapia" External link

em Friday, December 7, 2018 11:55:00 AM EAT

Roger Dansey disse : "Esta é a sexta indicação aprovada pela FDA para o ADCETRIS em tumores malignos linfoides e a segunda como um tratamento de primeira linha em combinação com quimioterapia" External link

noticias-terra-br Friday, December 7, 2018 11:49:00 AM EAT

Roger Dansey sagte : "Dies ist die sechste von der FDA zugelassene Indikation für ADCETRIS bei lymphatischen Malignomen und die zweite als Erstbehandlung in Kombination mit Chemotherapie" External link

finanznachrichten-en Thursday, December 6, 2018 10:38:00 AM EAT

Roger Dansey said : "This initial evaluation of the combination of Keytruda and Halaven is encouraging and represents an important part of our multi-pronged effort to bring forward new potential approaches for patients with this type of cancer," External link

rttnews Monday, December 12, 2016 4:19:00 PM EAT

Roger Dansey said : "Little progress has been made in metastatic triple-negative breast cancer, which is an aggressive and difficult-to-treat cancer. This initial evaluation of the combination of KEYTRUDA and HALAVEN is encouraging and represents an important part of our multi-pronged effort to bring forward new potential approaches for patients with this type of cancer," External link

prnewswire Monday, December 12, 2016 3:31:00 PM EAT

Roger Dansey told : “Immunotherapy is certainly the future when it comes to treating cancer… The problem with any treatment that is not immune based is that cancer cells can find a way to circumvent whatever the treatment is,” External link

jordantimes Sunday, October 16, 2016 3:43:00 AM EAT

Roger Dansey said : "Now, with longer follow-up, we continue to show clinically meaningful outcomes with KEYTRUDA as monotherapy in these ipilimumab-refractory patients," External link

finanznachrichten-en Saturday, October 8, 2016 5:19:00 PM EAT

Roger Dansey said : “Now, with longer follow-up, we continue to show clinically meaningful outcomes with KEYTRUDA as monotherapy in these ipilimumab-refractory patients,” External link

marketwatch Saturday, October 8, 2016 4:13:00 PM EAT

Roger Dansey said : “Now, with longer follow-up, we continue to show clinically meaningful outcomes with KEYTRUDA as monotherapy in these ipilimumab-refractory patients,” External link

4-traders Saturday, October 8, 2016 4:11:00 PM EAT

Roger Dansey said : “We have a growing body of evidence of KEYTRUDA’s activity in a range of cancers and treatment settings including the first-line treatment of patients with advanced urothelial cancer who will not tolerate cisplatin-based therapy,” External link

marketwatch Saturday, October 8, 2016 9:26:00 AM EAT



Key Titles and Phrases Count Lang Last Seen
vice president100.00%EN12/12/201612/12/2016
Names Lang Count
Roger DanseyEN90.00%
Roger DanseyIT10.00%


<<10<12345678910>>>10
<<10<12345678910>>>10

Tools

Load latest edition

Saturday, November 28, 2020

5:18:00 AM EAT


Quotes... Explore Relations


EMM Visual Explorer